“Evaluation of Myelosupression during Imatinib Mesylate Therapy in Patients with Chronic Myeloid Leukaemia”, J. Armed Forces Med. Coll., vol. 15, no. 2, pp. 189–192, Dec. 2020, doi: 10.3329/jafmc.v15i2.50833.